profit from every $100 of sales.
$0$100
Zepp Health
$2.38-0.42% today
-90.9% in 1 year
1-year low $2.201-year high $32.51
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Zepp Health sold, what it kept, and what it did with the cash.
Sales went from $614 million in 2022 to $259 million in 2025, with -$40.1 million of profit last year.
SalesProfit
Zepp Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Zepp Health | No profit yet | ||
 Apple | 39.1× · Expensive | ||
 Samsung Electronics | 31.7× · Expensive | ||
 Sony | 21.6× · Fair price | ||
 Xiaomi | 15.8× · Fair price |
AI analysis
An AI analyst reads Zepp Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 614 | 353 | 183 | 259 | |
| 119 | 92 | 70 | 99 | |
| -62 | -30 | -47 | -29 | |
| -39 | -20 | -47 | -25 | |
| -43 | -31 | -76 | -40 | |
| -2.71 | -1.96 | -4.64 | -2.56 | |
| 19.4% | 26.2% | 38.5% | 38.3% | |
| -10.1% | -8.6% | -25.9% | -11.3% | |
| -7.0% | -8.8% | -41.5% | -15.5% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 764 | 636 | 529 | 565 |
| Cash | 129 | 134 | 91 | 57 |
| Total debt | 250 | 196 | 182 | 229 |
| Total liabilities | 374 | 283 | 276 | 350 |
| 387 | 351 | 252 | 215 | |
| 15 | 15 | 16 | 16 | |
| -5.9% | -4.0% | -9.5% | -5.3% | |
| -11.2% | -8.8% | -30.1% | -18.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -117 | 43 | -24 | -26 | |
| 1 | 2 | 1 | 1 | |
| -119 | 41 | -26 | -26 | |
| Dividends paid | 6 | 0 | 0 | – |
| 8 | 3 | 2 | 1 | |
| 7 | 9 | 5 | 2 |
Valuation
- –
- 34.0×
- –
- 0.0×
- 0.1×
- –
- –
- -75.9%
- -114.8%
- 0.0%
Profitability
- 38.3%
- -11.3%
- -15.5%
- -10.1%
- -6.8%
- -7.2%
- -17.9%
- -7.3%
- -10.8%
- 17.6%
Growth
- −25.0%
- –
- −2.3%
- –
- −49.9%
Financial health
- –
- 1.06
- 40.4%
- -5.2×
- 1.02
- 0.77
- 0.47
How it ranks in Technology
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 11%of 974
Bottom 10%of 975
Bottom 1%of 982
Bottom 1%of 985
What analysts expect
- Average price target
- $12.00
- Range
- $12.00 – $12.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 16, 2026 | -0.40 | – | – |
| Nov 4, 2025 | -0.04 | – | – |
| Aug 3, 2025 | -0.39 | – | – |
| May 19, 2025 | -1.13 | – | – |
| Mar 26, 2025 | -1.40 | 0.22 | −723.9% |
| Nov 18, 2024 | -0.78 | 0.17 | −558.6% |
| Aug 21, 2024 | -0.60 | 0.02 | −2,685.1% |
| May 20, 2024 | -0.76 | -0.03 | −2,433.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
13No pass
Benjamin Graham
54No pass
Philip Fisher
34No pass
Peter Lynch
18No pass
Joel Greenblatt
0No pass
Charlie Munger
19No pass
Terry Smith
11No pass
Questions about Zepp Health
Is Zepp Health a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Zepp Health AI analysis
What does Zepp Health do?
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. It is in Consumer Electronics.
Does Zepp Health pay a dividend?
No. Zepp Health does not pay a dividend at the moment; in 2025 it returned $1.24 million to shareholders by buying back its own shares.
Is Zepp Health stock halal?
No. Zepp Health does not pass our halal screen: its debt is 656% of its market value, at or above the 33% limit. How we check
How has Zepp Health stock done over the past year?
Down 90.9% over the past twelve months, to $2.38. It traded between $2.20 and $32.51 and is 92.7% below its high.
Who are Zepp Health's competitors?
The largest listed companies in the same industry are Apple, Samsung Electronics, Sony and Xiaomi. The peers table on this page compares their profit, growth and price with Zepp Health's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.